Sort   by:  
 Page size 
UnknownCombining PGT-A with PGT-M risks trying to do too much.
Not available
S-EPMC9474767 | biostudies-literature
UnknownA Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.
Not available
S-EPMC4857465 | biostudies-literature
UnknownMortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of Monocytes.
Not available
S-EPMC5849097 | biostudies-literature
UnknownFamily-related non-abuse adverse life experiences occurring for adults diagnosed with eating disorders: a systematic review.
Not available
S-EPMC7374817 | biostudies-literature
UnknownA qualitative study on the multi-level process of resilience development for adults recovering from eating disorders.
Not available
S-EPMC8191215 | biostudies-literature
UnknownPrevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study.
Not available
S-EPMC8500620 | biostudies-literature
UnknownCardiac ryanodine receptor distribution is dynamic and changed by auxiliary proteins and post-translational modification.
Not available
S-EPMC6994221 | biostudies-literature
UnknownEarly ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.
Not available
S-EPMC4527410 | biostudies-literature
UnknownOn-surface synthesis of a doubly anti-aromatic carbon allotrope.
Not available
S-EPMC10686826 | biostudies-literature
UnknownCATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
Not available
S-EPMC8587583 | biostudies-literature
Sort   by:  
 Page size